Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Rivian CEO RJ Scaringe Talks R2 Model
08:44

BMW North America CEO Sebastian Mackensen Talks New Luxury Car, Electric Vehicles
08:54

United Airlines CEO Scott Kirby Talks Potential American Airlines Merger
10:39